Unions Oppose Naming Pharma Head To Thai Government Board
This article was originally published in PharmAsia News
A proposal to place a pharmaceutical industry representative on Thailand's Government Pharmaceutical Organisation has drawn a strong protest from the agency's labor union. The union staged a rally in front of the agency headquarters, calling the appointment an affront to public health affairs. The public health minister had appointed Teera Chakajnarodom, president of the Pharmaceutical Research and Manufacturers Association, to its board. The union noted the appointee has been a strong opponent of the government's compulsory license policy designed to lower prices on key drugs. (Click here for more
You may also be interested in...
Infographic timeline looks at key moments in the history of vaccine development, from the first vaccine against smallpox to the polio field trial involving 1.8 million children to the flurry of vaccines created by ‘the scientist who saved more lives than all other scientists combined.’
Vaccine experts, including R&D leaders at Pfizer and Sanofi, describe what has been unique in developing a vaccine for the novel coronavirus, lessons learned from previous vaccines, and challenges that lie ahead.
CV Defense, the second launch in the firm’s new immune-support line (without cannabidiol), is built around palmitoylethanolamide and other nutrients and botanicals to “optimize immune response.” CV Sciences touts the immunity range as complementary to its PlusCBD brand, which is in the process of rolling out dozens of new products in updated packaging.